Cite
HARVARD Citation
Straka, C. et al. (2021). Full or intensity‐reduced high‐dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma. European journal of haematology. pp. 529-542. [Online].